ABOUT 3D BOLUS
3D Bolus is a software application that provides practitioners with turn-key software that enables printing of patient-specific uniform thickness bolus, Modulated Bolus for MERT (modulated electron radiation therapy), High Dose Rate (HDR) surface brachytherapy and other potential ancillary devices. All products are derived directly from the CT planning images.
3D Bolus software fully integrates with existing treatment planning systems allowing the planning software to calculate the treatment plan with the 3D Bolus design.All 3D Bolus products are designed and tested with full involvement by end users in the field. 3D Bolus was developed by Dr. James Robar in partnership with Dalhousie University in Halifax, Canada. 3D Bolus Inc has the exclusive worldwide license for the use of the technology and is moving forward with its commercialization. We currently have a fully operating software prototype in clinical use for specialized cases in Nova Scotia and via our collaborators in San Francisco, California.
3D Bolus has achieved its CE Mark and ISO 13485 and is selling in international markets including Europe and Asia. 3D Bolus is currently in the process of attaining FDA 510K approval, which is projected to be completed by January 2018. During this time, the solution can used for testing and research purposes.
UNIFORM THICKNESS 3D BOLUS IS AN ALTERNATIVE TO STANDARD BOLUS SHEETS
Software generated 3D Bolus being investigated for use on a post-mastectomy chestwall patient. A software generated 3D Bolus is custom-fit to eliminate air gaps and improve the accuracy, efficiency and reproducibility of treatment.
3D BOLUS SOFTWARE IS BEING DEVELOPED TO PROVIDE A PRACTICAL AND LOW COST APPROACH TO MODULATED ELECTRON RADIATION THERAPY (MERT)
7 yr old child with rhabdomysosarcoma. The top image displays an electron treatment using conventional bolus while the bottom image shows an investigational use our SMART Bolus for MERT for the same treatment.. The shape of the bolus tailors the electron dose distribution to the target volume, sparing the normal structures directly beneath. In this case the dose to the left kidney was decreased by 38%.
The shape of the 3D Bolus modulates the electron beam to achieve conformity of the prescription isodose to the tumor volume.